The U.S. Food and Drug Administration has approved Novo Nordisk's (NYSE: NVO) Wegovy HD injection, a higher 7.2-milligram dose of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE